LIFE-U:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund (USD)

ETF | Others |

Last Closing

CAD 18.71

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.37K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.18 (+0.53%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.14 (-0.47%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.24 (-0.92%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.13 (+0.37%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.20 (+0.42%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.09 (+0.40%)

CAD 2.78B

ETFs Containing LIFE-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.47% 49% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.47% 47% F 42% F
Trailing 12 Months  
Capital Gain -9.70% 8% B- 17% F
Dividend Return 1.13% 32% F 20% F
Total Return -8.57% 7% C- 15% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -2.12% 11% F 19% F
Dividend Return -1.74% 10% F 13% F
Total Return 0.38% 42% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 6.02% 74% C 88% B+
Risk Adjusted Return -28.92% 9% A- 9% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.